Back to search

SME-4.02 Research for the benefit of SMEs

Development of a Point of Care microfluidic chip unit and self-sampling device for cervical cancer screening and platform technology for Nucleic Acid Detection at the Point of Care

Awarded: NOK 3.8 mill.

Source:

Project Manager:

Not available

Project Number:

262243

Application Type:

Project Period:

2010 - 2012

Development of a Point of Care microfluidic chip unit and self-sampling device for cervical cancer screening and platform technology for Nucleic Acid Detection at the Point of Care

-

Funding scheme:

SME-4.02 Research for the benefit of SMEs

Funding Sources